What are the first line treatment options in HCC patients with significant baseline proteinuria?
Would you consider single agent IO such as Nivolumab, given data are not strong (Checkmate 459)?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Medical College of Wisconsin
Answered on
Tough problem! Treatment of advanced HCC is quite challenging since medical oncologists have to account for the compromised liver function (due to the underlying liver disease) over and beyond the disease burden, when making treatment decisions. Therefore, treatment decisions are often made after we...
Join for free or sign in to see the full answer